• Two cases of persistent hematuria associated with the presence of sickle cell hemoglobin were treated intravenously with triglycyl vasopressin, a drug not previously used for this condition. One patient, a 16-year-old boy, had hemoglobin SC, and the other patient was a 30-year-old woman with hemoglobin AS. Both patients had a history of severe hematuria persisting over several months, resistant to the usual forms of therapy, and requiring numerous tranfusions. In each patient, the condition responded to intravenous triglycyl vasopressin therapy, with cessation of hematuria. Experimental studies in dogs indicate that triglycyl vasopressin reduces renal blood flow substantially. Further trial of triglycyl vasopressin in severe hematuria associated with the presence of sickle cell hemoglobin appears to be indicated.
(Arch Intern Med 140:1589-1593, 1980)
John EG, Schade SG, Spigos DG, Cort JH, Rosenthal IM. Effectiveness of Triglycyl Vasopressin in Persistent Hematuria Associated With Sickle Cell Hemoglobin. Arch Intern Med. 1980;140(12):1589–1593. doi:10.1001/archinte.1980.00330230035011
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: